Nothing Special   »   [go: up one dir, main page]

AU2002953094A0 - Immunomodulating compositions, processes for their production and uses therefor - Google Patents

Immunomodulating compositions, processes for their production and uses therefor

Info

Publication number
AU2002953094A0
AU2002953094A0 AU2002953094A AU2002953094A AU2002953094A0 AU 2002953094 A0 AU2002953094 A0 AU 2002953094A0 AU 2002953094 A AU2002953094 A AU 2002953094A AU 2002953094 A AU2002953094 A AU 2002953094A AU 2002953094 A0 AU2002953094 A0 AU 2002953094A0
Authority
AU
Australia
Prior art keywords
processes
production
uses therefor
immunomodulating compositions
immunomodulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002953094A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Original Assignee
University of Queensland UQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Priority to AU2002953094A priority Critical patent/AU2002953094A0/en
Publication of AU2002953094A0 publication Critical patent/AU2002953094A0/en
Priority to US10/524,539 priority patent/US20060182726A1/en
Priority to CA002494675A priority patent/CA2494675A1/en
Priority to PCT/AU2003/001021 priority patent/WO2004015056A2/en
Priority to EP03783854A priority patent/EP1546310A4/en
Priority to AU2003249780A priority patent/AU2003249780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A61K39/4614—
    • A61K39/4615—
    • A61K39/4621—
    • A61K39/4622—
    • A61K39/4634—
    • A61K39/4637—
    • A61K39/46433—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002953094A 2002-08-12 2002-12-04 Immunomodulating compositions, processes for their production and uses therefor Abandoned AU2002953094A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2002953094A AU2002953094A0 (en) 2002-12-04 2002-12-04 Immunomodulating compositions, processes for their production and uses therefor
US10/524,539 US20060182726A1 (en) 2002-08-12 2003-08-12 Immunomodulating compositions, processes for their production and uses therefor
CA002494675A CA2494675A1 (en) 2002-08-12 2003-08-12 Immunomodulating compositions, processes for their production and uses therefor
PCT/AU2003/001021 WO2004015056A2 (en) 2002-08-12 2003-08-12 Immunomodulating compositions, processes for their production and uses therefor
EP03783854A EP1546310A4 (en) 2002-08-12 2003-08-12 Immunomodulating compositions, processes for their production and uses therefor
AU2003249780A AU2003249780A1 (en) 2002-08-12 2003-08-12 Immunomodulating compositions, processes for their production and uses therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002953094A AU2002953094A0 (en) 2002-12-04 2002-12-04 Immunomodulating compositions, processes for their production and uses therefor

Publications (1)

Publication Number Publication Date
AU2002953094A0 true AU2002953094A0 (en) 2002-12-19

Family

ID=29408816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002953094A Abandoned AU2002953094A0 (en) 2002-08-12 2002-12-04 Immunomodulating compositions, processes for their production and uses therefor

Country Status (4)

Country Link
EP (1) EP1546310A4 (en)
AU (1) AU2002953094A0 (en)
CA (1) CA2494675A1 (en)
WO (1) WO2004015056A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1224264B1 (en) * 1999-10-15 2010-01-27 Baylor Research Institute Use of allogeneic cell lines to load antigen-presenting cells to elicit immune responses
HU0301358D0 (en) 2003-05-14 2003-07-28 Debreceni Egyetem Novel use of ppargamma agonists
DE102005016234B4 (en) * 2005-04-08 2008-05-15 Tgc Biomics Gmbh Method of introducing exogenous antigen into the MHC I presentation pathway of cells
CN101646418B (en) * 2006-10-12 2013-07-17 昆士兰大学 Compositions and methods for modulating immune responses
EP2077821B1 (en) 2006-10-12 2019-08-14 The University Of Queensland Compositions and methods for modulating immune responses
WO2014141244A1 (en) 2013-03-12 2014-09-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Synthetic peptides for the treatment of autoimmune diseases
CN110923206A (en) * 2018-09-20 2020-03-27 天津贝罗尼生物科技有限公司 Method for preparing antigen presenting cell

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system

Also Published As

Publication number Publication date
WO2004015056A2 (en) 2004-02-19
CA2494675A1 (en) 2004-02-19
WO2004015056A3 (en) 2004-04-01
EP1546310A4 (en) 2006-05-17
EP1546310A2 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
EP1638993A4 (en) Immunomodulating compositions, uses therefor and processes for their production
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
AU2003222544A1 (en) Homing process
AU2003273249A1 (en) Laminate structures, methods for production thereof and uses therefor
AU2003266194A1 (en) Nanocomposite, method for production and use thereof
AU2003285288A1 (en) Composition
AU2002950744A0 (en) Composition
AU2003264207A1 (en) 1,4-substituted cyclohexane derivatives
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2003210777A1 (en) Improved desulfurization process
AU2003234631A1 (en) Coating process
AU2003235708A1 (en) Polytartrate composition
AU2003278355A1 (en) Process
AU2003203117A1 (en) Instant modified flour
AU2002361132A1 (en) Plasticine composition and process for production thereof
AU2003208411A1 (en) Anti-glycolytic composition
AU2003273369A1 (en) Driveway, driveway module, and method for the production thereof
AU2002953094A0 (en) Immunomodulating compositions, processes for their production and uses therefor
AUPS334602A0 (en) Glutathione production
AU2003249550A1 (en) Water-desalting plant
AU2003902875A0 (en) Immunomodulating compositions, uses therefor and processes for their production
AU2003281532A1 (en) Antioxidant and process for producing the same
AUPS225402A0 (en) Modified cell production
AU2003282700A1 (en) Kavalactone product
AU2003225714A1 (en) Process for making perylene pigment compositions